VANGUARD GROUP INC - UNITY BIOTECHNOLOGY INC ownership

UNITY BIOTECHNOLOGY INC's ticker is and the CUSIP is 91381U200. A total of 37 filers reported holding UNITY BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.4%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of UNITY BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$1,347,845
-6.1%
561,602
-0.2%
0.00%
Q2 2023$1,435,543
+68.1%
562,958
+7.5%
0.00%
Q1 2023$853,996
-29.8%
523,924
+18.0%
0.00%
Q4 2022$1,216,077443,8240.00%
Other shareholders
UNITY BIOTECHNOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Founders Fund V Management, LLC 49,172$80,1506.17%
ARCH Venture Management, LLC 1,004,817$1,637,8520.79%
Mayo Clinic 157,198$256,2330.21%
Alyeska Investment Group, L.P. 1,286,000$2,096,1800.02%
Arete Wealth Advisors, LLC 10,392$1420.01%
UBS OCONNOR LLC 213,040$347,2550.01%
Cercano Management LLC 41,238$67,2180.00%
Johnson Midwest Financial, LLC 661$1,0770.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 50,000$81,5000.00%
ExodusPoint Capital Management, LP 93,597$1530.00%
View complete list of UNITY BIOTECHNOLOGY INC shareholders